FDA Inspection 1020931 - Ammar Hemaidan - July 21, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Ammar Hemaidan, with an inspection on July 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Ammar Hemaidan
Inspection Date: July 21, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 389ce53c-938f-4b2a-be1e-2bde98a3519f

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.